SNRI ‘Shows Promise’ for Comorbid ADHD, PTSD

Atomoxetine, a selective norepinephrine reuptake inhibitor (SNRI), may improve outcomes for patients with both attention-deficit/hyperactivity disorder (ADHD) and posttraumatic stress…

Nearly 4 in 10 Cancer Deaths Attributable to Cigarette Smoking

Although rates of smoking have been declining in the United States, smoking is still contributing substantially to the cancer burden,…